a celebration of NCCN's 20th year working to improve the quality, effectiveness, and efficiency of cancer care so that patients can lead better lives. We celebrated this milestone with an agenda comprising a multitude of experts throughout the oncology landscape, as well as exciting new developments in more than 15 cancer types and emerging therapies. This year's conference was a true testament to the magnitude of impact NCCN and its Member Institutions have had on the treatment of cancer care over the past 2 decades, and we present these Highlights as a synopsis of the proceedings in this special issue of
NCCN has also enriched an already well-established education program with an online learning management platform, providing oncology clinicians with expanded and easy-to-access continuing education opportunities based on NCCN content. Each year, more than 175 NCCN continuing education programs are conducted for medical professionals around the world. Moreover, NCCN offers a certificate program-the NCCN International Educational Activities Program-that recognizes physicians outside the United States for completion of NCCN educational content hours.
NCCN also recently announced a collaboration with Foundation for Excellence and Quality in Oncology (ECO) to publish Spanish translations of NCCN Guidelines and regional adaptions for Spain, including breast, colorectal, non-small cell lung, and prostate cancers and melanoma.
NCCN continues our initiative with McKesson Specialty Health to develop value-based pathways for the treatment of common cancers. These clinical practice guidelines are jointly developed by McKesson Specialty Health, The US Oncology Network, and NCCN to consider efficacy, toxicity, and cost when evaluating treatment options in radiation oncology, and are based on the NCCN Guidelines.
These are just a few of the programs and initiatives in the works and on the horizon. Through these programs and initiatives, NCCN aspires to be the world leader in defining and advancing high-quality, high-value cancer care. But none of that is possible without the contributions and support of our Member Institutions and the larger oncology community. We believe that JNCCN readers, whether you are from an NCCN Member Institution or not, also contribute to improving the quality of cancer care. We embrace this collaboration and partnership, and look forward to working with you now and in the future.
Your support of NCCN and our programs is invaluable, and I hope that you will continue to participate in the NCCN Annual Conference (March 31-April 2, 2016) and other NCCN activities and programs. Please visit NCCN.org for more information and to access programs such as the NCCN Guidelines and to watch, and participate in, NCCN's continuing evolution.
